Scarica l'app Stockscreener
8.91
1.87%
-0.17
Precedente Chiudi:
$9.08
Aprire:
$8.84
Volume 24 ore:
71,449
Relative Volume:
0.62
Capitalizzazione di mercato:
$289.82M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-2.52%
1M Prestazione:
+15.71%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$8.84
$9.25
Intervallo di 1 settimana:
$8.52
$9.78
Portata 52W:
$6.565
$13.47
Jade Biosciences Inc Stock (JBIO) Company Profile
Nome
Jade Biosciences Inc
Settore
Industria
Telefono
617-443-2400
Indirizzo
930 WINTER STREET, WALTHAM
Confronta JBIO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
JBIO
Jade Biosciences Inc
|
8.883 | 417.63M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.62 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.68 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
552.20 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
809.14 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.45 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Jade Biosciences Inc Stock (JBIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-09 | Iniziato | BTIG Research | Buy |
| 2025-07-14 | Iniziato | Jefferies | Buy |
| 2025-06-16 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2025-05-07 | Iniziato | Wedbush | Outperform |
| 2025-05-05 | Iniziato | Stifel | Buy |
| 2025-05-02 | Iniziato | TD Cowen | Buy |
| 2024-06-18 | Downgrade | Evercore ISI | Outperform → In-line |
| 2024-06-18 | Downgrade | TD Cowen | Buy → Hold |
| 2024-06-18 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-06-17 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-06-17 | Downgrade | Guggenheim | Buy → Neutral |
| 2024-06-17 | Downgrade | Wedbush | Outperform → Neutral |
| 2024-03-25 | Ripresa | Jefferies | Buy |
| 2023-12-08 | Iniziato | Wells Fargo | Equal Weight |
| 2023-03-01 | Iniziato | Guggenheim | Buy |
| 2022-12-06 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2022-09-19 | Ripresa | Wedbush | Outperform |
| 2022-08-16 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-02-11 | Iniziato | BTIG Research | Buy |
| 2021-07-26 | Iniziato | Cowen | Outperform |
| 2021-07-26 | Iniziato | Evercore ISI | Outperform |
| 2021-07-26 | Iniziato | Jefferies | Buy |
| 2021-07-26 | Iniziato | Wedbush | Outperform |
Mostra tutto
Jade Biosciences Inc Borsa (JBIO) Ultime notizie
How Jade Biosciences Inc. stock reacts to inflationary pressuresMarket Activity Recap & Daily Technical Forecast Reports - newser.com
Multi asset correlation models including Jade Biosciences Inc.Index Update & AI Driven Stock Movement Reports - newser.com
Jade Biosciences Inc. stock daily chart insightsJuly 2025 Review & Consistent Profit Trade Alerts - newser.com
Visualizing Jade Biosciences Inc. stock with heatmaps2025 Valuation Update & Safe Capital Growth Tips - newser.com
Jade Biosciences (NASDAQ:JBIO) Research Coverage Started at BTIG Research - Defense World
Visual trend scoring systems applied to Jade Biosciences Inc.2025 Top Gainers & Daily Volume Surge Signals - newser.com
Q3 Earnings Forecast for Jade Biosciences Issued By Wedbush - MarketBeat
BTIG Research Begins Coverage on Jade Biosciences (NASDAQ:JBIO) - MarketBeat
Jade Biosciences, Inc. (NASDAQ:JBIO) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Analyzing drawdowns of Jade Biosciences Inc. with statistical toolsAnalyst Upgrade & High Accuracy Swing Trade Signals - newser.com
Jade Biosciences stock initiated with Buy rating at BTIG on APRIL inhibitor potential - Investing.com Canada
BTIG Initiates Coverage of Jade Biosciences (JBIO) with Buy Recommendation - Nasdaq
BTIG Initiates Jade Biosciences at Buy With $28 Price Target - MarketScreener
Jade Biosciences (NASDAQ:JBIO) Receives Sell (E-) Rating from Weiss Ratings - MarketBeat
Jade Biosciences offers $135 million equity through private placement - MSN
Jade Biosciences discloses JADE-201 for autoimmune diseases - BioWorld MedTech
Jade Biosciences Announces JADE201, a Potentially - GlobeNewswire
Jade Biosciences Secures $135 Million In PIPE Deal - Finimize
Jade Biosciences Unveils JADE201 Antibody to Potentially Treat Autoimmune Diseases - MarketScreener
Jade Biosciences unveils JADE201 antibody targeting BAFF-R By Investing.com - Investing.com Nigeria
Jade Biosciences secures $135 million in private financing By Investing.com - Investing.com Canada
Jade Biosciences Secures $135 Million in Private Placement - TipRanks
Jade Biosciences unveils JADE201 antibody targeting BAFF-R - Investing.com
Jade Biosciences Announces JADE201, a Potentially Best-in-Class Half-Life Extended Afucosylated Anti-BAFF Receptor Monoclonal Antibody in Development for Autoimmune Diseases - The Manila Times
Jade Biosciences Announces $135 Million Private Placement - GlobeNewswire
Jade Biosciences Announces $135 Million Private Placement - GlobeNewswire Inc.
Real time alert setup for Jade Biosciences Inc. performanceJuly 2025 Price Swings & Expert Curated Trade Setup Alerts - newser.com
How to integrate Jade Biosciences Inc. into portfolio analysis toolsQuarterly Growth Report & Safe Investment Capital Preservation Plans - newser.com
Jade Biosciences, Inc. announced that it expects to receive $135 million in funding - MarketScreener
Tick level data insight on Jade Biosciences Inc. volatility2025 Fundamental Recap & AI Driven Stock Price Forecasts - newser.com
Is Jade Biosciences Inc. stock vulnerable to regulatory risksJuly 2025 Breakouts & Expert Verified Stock Movement Alerts - newser.com
How strong is Jade Biosciences Inc. stock balance sheetQuarterly Earnings Report & High Conviction Buy Zone Alerts - newser.com
What drives Jade Biosciences Inc stock priceCandlestick Pattern Analysis & Minimize Portfolio Damage with Warnings - earlytimes.in
Jade Biosciences Inc Azioni (JBIO) Dati Finanziari
Non sono disponibili dati finanziari per Jade Biosciences Inc (JBIO). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
1.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):